Trial Profile
Phase I/II trial of the addition of taxol [paclitaxel] to high dose carboplatin and cyclophosphamide with autologous peripheral blood progenitor cell support in patients with breast cancer
Status:
Active, no longer recruiting
Phase of Trial:
Phase I/II
Latest Information Update: 27 Sep 2005
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary) ; Carboplatin; Cyclophosphamide
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 27 Sep 2005 New trial record.